Goran Smedegangrd

Title: Goran Smedegangrd: Innovator in Pharmaceutical Chemistry

Introduction

Goran Smedegangrd is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating autoimmune diseases. His innovative work has led to the creation of a unique compound that holds promise for medical applications.

Latest Patents

Goran Smedegangrd holds a patent for "Substituted salicylic acids," which describes a compound of the formula Het--NR--SO.sub.2 --Ph.sup.2 --A--Ph.sup.1 (COOH)(OH) and its tautomeric forms, salts, solvates, C.sub.1-6 alkyl esters, and pharmaceutical compositions. The compound is characterized by the presence of benzene rings, with carboxy and hydroxy groups positioned ortho to one another. The invention also details the preparation of the compound and its potential use as a drug, particularly for treating autoimmune diseases.

Career Highlights

Goran Smedegangrd has been associated with Pharmacia AB, where he has contributed to various research initiatives. His work has focused on the synthesis and application of novel pharmaceutical compounds, showcasing his expertise in the field.

Collaborations

Goran has collaborated with notable colleagues, including Hubert Agback and Leif G Ahrgren. These partnerships have enhanced the research and development efforts within the pharmaceutical domain.

Conclusion

Goran Smedegangrd's innovative contributions to pharmaceutical chemistry, particularly through his patented compound, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treatments for autoimmune diseases.